Literature DB >> 24328535

Detection of drug resistance-associated mutations in human immunodeficiency virus type 1 integrase derived from drug-naive individuals in Surabaya, Indonesia.

Tomohiro Kotaki1, Siti Qamariyah Khairunisa, Septhia Dwi Sukartiningrum, Adiana Mutamsari Witaningrum, Musofa Rusli, M Noor Diansyah, M Vitanata Arfijanto, Retno Pudji Rahayu, Masanori Kameoka.   

Abstract

Although human immunodeficiency virus type 1 (HIV-1) infection causes serious health problems in Indonesia, information in regard to drug resistance is limited. We performed a genotypic study on HIV-1 integrase derived from drug-naive individuals in Surabaya, Indonesia. Sequencing analysis revealed that no primary mutations associated with drug resistance to integrase inhibitors were detected; however, secondary mutations, V72I, L74I/M, V165I, V201I, I203M, and S230N, were detected in more than 5% of samples. In addition, V201I was conserved among all samples. Most integrase genes were classified into CRF01_AE genes. Interestingly, 40% of the CRF01_AE genes had an unusual insertion in the C-terminus of integrase. These mutations and insertions were considered natural polymorphisms since these mutations coincided with previous reports, and integrase inhibitors have not been used in Indonesia. Our results indicated that further studies may be required to assess the impact of these mutations on integrase inhibitors prior to their introduction into Indonesia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24328535     DOI: 10.1089/AID.2013.0271

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

1.  Pre-Treatment Integrase Inhibitor Resistance and Natural Polymorphisms among HIV-1 Subtype C Infected Patients in Ethiopia.

Authors:  Dawit Assefa Arimide; Zsófia Ilona Szojka; Kidist Zealiyas; Atsbeha Gebreegziabxier; Fekadu Adugna; Sviataslau Sasinovich; Per Björkman; Patrik Medstrand
Journal:  Viruses       Date:  2022-03-30       Impact factor: 5.818

2.  Prevalence of resistance to integrase strand-transfer inhibitors (INSTIs) among untreated HIV-1 infected patients in Morocco.

Authors:  Najwa Alaoui; Moulay Abdelaziz El Alaoui; Nadia Touil; Hicham El Annaz; Marouane Melloul; Reda Tagajdid; Naoufal Hjira; Mohamed Boui; El Mostapha El Fahime; Saad Mrani
Journal:  BMC Res Notes       Date:  2018-06-08

3.  Transmission dynamics of HIV-1 subtype B strains in Indonesia.

Authors:  Shuhei Ueda; Adiana Mutamsari Witaningrum; Siti Qamariyah Khairunisa; Tomohiro Kotaki; Kazushi Motomura; Masanori Kameoka
Journal:  Sci Rep       Date:  2019-09-27       Impact factor: 4.379

4.  Interaction analysis of statistically enriched mutations identified in Cameroon recombinant subtype CRF02_AG that can influence the development of Dolutegravir drug resistance mutations.

Authors:  Sello Given Mikasi; Darren Isaacs; Rumbidzai Chitongo; George Mondide Ikomey; Graeme Brendon Jacobs; Ruben Cloete
Journal:  BMC Infect Dis       Date:  2021-04-23       Impact factor: 3.090

5.  High-level resistance to non-nucleos(t)ide reverse transcriptase inhibitor based first-line antiretroviral therapy in Ghana; A 2017 study.

Authors:  Prince Kofi Parbie; Christopher Zaab-Yen Abana; Dennis Kushitor; Theodore Worlanyo Asigbee; Nana Afia Asante Ntim; Gifty Addo-Tetebo; Maclean Richard Darko Ansong; Sampson Badu Ofori; Taketoshi Mizutani; Lucky Ronald Runtuwene; Masako Nishizawa; Koichi Ishikawa; Hiroshi Kiyono; William Kwabena Ampofo; Tetsuro Matano; Evelyn Yayra Bonney; Tadashi Kikuchi
Journal:  Front Microbiol       Date:  2022-08-25       Impact factor: 6.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.